Carlin S

ORCID: 0000-0002-5401-0648 · 1 paper in corpus

2013

Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine ·doi:10.2967/jnumed.113.119867

UnlabelledDespite their considerable advantages, many circulating biomarkers have well-documented limitations. One prominent shortcoming in oncology is a high frequency of false-positive indications for malignant disease in upfront diagnosi…